Samsara Analyst Ratings
List of conversion stocks [List of conversion stocks for parabolic signals]
○Buy conversion stock list Market Code Stock Name Close Price SAR Tokyo Prime <2269> Meiji HD 3640 3395<3925> D Standard 1600 1343<4206> Aika Kogyo 3312 3170<4331> T&G Needs 835 742<4973> High Purity 3260 2800<6240> Yamashin F 4
Looking Into Novanta's Recent Short Interest
Selling pressure dominates the market, especially in high-tech stocks, but there is strong buying interest on dips and a reluctance to decline.
The Nikkei average fell slightly for the third consecutive day. It ended the trading day at 38,362.53 yen, down 9.23 yen (with a volume of approximately 1.6 billion shares). Following the release of the 2024 Q2 earnings by the leading U.S. semiconductor company NVIDIA in extended hours trading, the semiconductor-related stocks and others were sold off. The Nikkei average dropped to 37,970.20 yen at the start of the trading session. However, there was a rebound below the psychological milestone of the 38,000 yen level, and there was also a movement to buy on dips, along with the yen exchange rate at 1.
Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today
NVIDIA's Earnings: 5 Reasons Why This Week's Report Could Shake Up Markets, AI Stocks, And The S&P 500
Illumina Analyst Ratings
Ready for Fed Rate Cuts? Biotech's Potential to Watch
Looking Into ServiceNow's Recent Short Interest
(IOT) - Analyzing Samsara's Short Interest
The Analyst Landscape: 5 Takes On Omnicell
Omnicell Analyst Ratings
Da Cheng Construction, Da Lin Group, etc. (additional) Rating
Upgraded - Bullish Code | Stock Name | Securities Company | Previous | After Change | ------|-----------------|-------------|---------|---------|<7013> | IHI | Mizuho | "Hold" | "Buy" | Downgraded - Bearish Code | Stock Name | Securities Company | Previous | After Change | ------|-------------
Intuitive Surgical Analyst Ratings
Goldman Sachs' Favorite Mutual Funds Positions That Are Overweight the Russell 1000
Market Whales and Their Recent Bets on NOW Options
Omnicell Announces Central Med Automation Service, A Subscription-Based Solution Designed To Help Health Systems Establish And Continuously Optimize Centralized Medication Management For CPCS And Similar Operations
$100 Invested In This Stock 10 Years Ago Would Be Worth $1,400 Today
Unpacking the Latest Options Trading Trends in Intuitive Surgical
'Bottom-fishing' Ideas Within Piper Sandler's Universe of Stocks